Cargando…

Radiofrequency ablation and cryoablation of renal tumours

Detalles Bibliográficos
Autores principales:	Kwan, K.G., Matsumoto, E.D.
Formato:	Texto
Lenguaje:	English
Publicado:	Multimed Inc. 2007
Materias:	Updates and Developments in Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891188/ https://www.ncbi.nlm.nih.gov/pubmed/17576462

Ejemplares similares

Electrochemotherapy of tumours
por: Sersa, G., et al.
Publicado: (2009)

Exosomes in tumour immunity
por: Clayton, A., et al.
Publicado: (2009)

Genomancy: predicting tumour response to cancer therapy based on the oracle of genetics
por: Williams, P.D., et al.
Publicado: (2009)

Comparison of Radiofrequency Ablation Versus Cryoablation For T1 Renal Tumors: An Evidence-Based Analysis of Comparative Outcomes
por: Shi, Hongjin, et al.
Publicado: (2022)

Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6
por: Chan, C.H.F., et al.
Publicado: (2007)

The effectiveness of RENAL nephrometry score in ablated renal tumors via radiofrequency ablation or cryoablation
por: ALADAĞ KURT, Seda, et al.
Publicado: (2019)

Radiofrequency Ablation, Cryoablation, and Microwave Ablation for the Treatment of Small Renal Masses: Efficacy and Complications
por: Bertolotti, Lorenzo, et al.
Publicado: (2023)

Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours
por: Wah, Tze M, et al.
Publicado: (2014)

Hepatocyte growth factor and the hepatocyte growth factor receptor signalling complex as targets in cancer therapies
por: Jiang, W.G.
Publicado: (2007)

The antitumour activities of statins
por: Takahashi, H.K., et al.
Publicado: (2007)

Radiolabelled monoclonal antibodies in the treatment of metastatic cancer
por: Goldenberg, D.M.
Publicado: (2007)

Targeting transforming growth factor β to enhance cancer immunotherapy
por: Hahn, T., et al.
Publicado: (2006)

Radiation oncology: Times of practice change
por: Freeman, C.R., et al.
Publicado: (2007)

Promising agents for chemoprevention of skin cancer
por: Stratton, S.P., et al.
Publicado: (2006)

Comparing the results of bisphosphonate use in clinical trials with actual practice: a case of apples and oranges?
por: Gainford, M.C., et al.
Publicado: (2006)

Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?
por: Bonfil, R.D., et al.
Publicado: (2008)

Fire or Ice: Cryoablation as a Viable Alternative to Radiofrequency Ablation for Renal Artery Denervation?
por: Anwaruddin, Saif, et al.
Publicado: (2022)

Retinoids, vitamin D, invasion, and metastasis
por: Tokar, E.J., et al.
Publicado: (2006)

Comparison of Radiofrequency Ablation and Cryoablation for the Recovery of Atrial Contractility and Survival
por: Kim, Kang Min, et al.
Publicado: (2018)

Cancer symptom control trials: how may we advance this field?
por: MacDonald, N.
Publicado: (2007)

Role of vaccine therapy in cancer: biology and practice
por: Schlom, J., et al.
Publicado: (2007)

Protein tyrosine phosphatases: new markers and targets in oncology?
por: Hardy, S., et al.
Publicado: (2008)

The role of dna hypermethylation and demethylation in cancer and cancer therapy
por: Szyf, M.
Publicado: (2008)

Anal cancer and human papillomaviruses in heterosexual men
por: Nyitray, A.
Publicado: (2008)

Cancer and thrombosis: recent advances
por: Solymoss, S.
Publicado: (2008)

Receptor tyrosine kinases: role in cancer progression
por: Sangwan, V., et al.
Publicado: (2006)

Percutaneous Ablation of T1 Renal Masses: Comparative Local Control and Complications after Radiofrequency and Cryoablation
por: Bertolotti, Lorenzo, et al.
Publicado: (2023)

Radiofrequency Ablation versus Cryoablation in the Treatment of Paroxysmal Atrial Fibrillation: A Meta-Analysis
por: Hachem, Ali H., et al.
Publicado: (2018)

Safety and effectiveness of percutaneous renal cryoablation with conscious sedation
por: Patel, Sagar Rohitkumar, et al.
Publicado: (2020)

Unresectable Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Combined With Microwave Ablation vs. Combined With Cryoablation
por: Wei, Jialiang, et al.
Publicado: (2020)

Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
por: Gu, Cheng-Yuan, et al.
Publicado: (2021)

Efficacy and safety of cryoablation for localized renal tumor as an alternative approach to partial nephrectomy
por: Barjolle, Irène, et al.
Publicado: (2023)

Radiofrequency ablation of lung tumours
por: Bargellini, Irene, et al.
Publicado: (2011)

Radiofrequency ablation of lung tumours
por: Goh, PYT
Publicado: (2006)

Cryoablation Versus Radiofrequency Ablation for Hepatic Malignancies: A Systematic Review and Literature-Based Analysis
por: Wu, Shunquan, et al.
Publicado: (2015)

Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians
por: Schullian, Peter, et al.
Publicado: (2019)

Endogenous Heat‐Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma
por: Domingo‐Musibay, Evidio, et al.
Publicado: (2017)

Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer
por: Kraeber–Bodéré, F., et al.
Publicado: (2009)

The influence of iatrogenic atrial septal defect on the prognosis of patients with atrial fibrillation between cryoablation and radiofrequency ablation
por: Yang, Ying, et al.
Publicado: (2020)

The efficacy of radiofrequency ablation versus cryoablation in the treatment of single hepatocellular carcinoma: A population‐based study
por: Chen, Lei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uf4egbe4fputlvas42ee4kganl